Xenon Pharmaceuticals Inc. (XENE) Insider Trading
Sector: Biotechnology · Market Cap: $6.2B · 0 insider purchases in the last 7 days
No open market insider purchases at Xenon Pharmaceuticals Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track XENE on your watchlist.
Start for FreeAbout Xenon Pharmaceuticals Inc. Insider Trading
2 insiders at Xenon Pharmaceuticals Inc. (XENE) have purchased stock in the past 90 days, totaling $1.7M across 2 transactions (45,000 shares).
The most recent purchase was by CFO Kelly Thomas Patrick on September 30, 2026 — a $560K buy of 15,000 shares at $37.32, bringing his total holdings to 15,000 shares.
Insiders who purchased: MORTIMER IAN (CEO, 1 buy totaling $1.1M); Kelly Thomas Patrick (CFO, 1 buy totaling $560K).
This insider buying is notable given that XENE had no recorded open market purchases in the nine months before that.
XENE is in the Biotechnology sector within the Biotechnology industry with a market cap of $6.2B.
Track XENE insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.